| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Correction to Lancet Haematol 2016; 3: e323
|
|
|
2016
|
3 |
8 |
p. e361-
1 p.
|
artikel
|
| 2 |
Costs of haematological disease high and rising
|
Green, Tony
|
|
2016
|
3 |
8 |
p. e353-e354
nvt p.
|
artikel
|
| 3 |
Direct oral anticoagulants and cancer: no swansong yet for the low-molecular-weight heparins
|
Noble, Simon I R
|
|
2016
|
3 |
8 |
p. e357-e358
nvt p.
|
artikel
|
| 4 |
Doping and athlete health
|
The Lancet Haematology,
|
|
2016
|
3 |
8 |
p. e352-
1 p.
|
artikel
|
| 5 |
Economic burden of malignant blood disorders across Europe: a population-based cost analysis
|
Burns, Richeal
|
|
2016
|
3 |
8 |
p. e362-e370
nvt p.
|
artikel
|
| 6 |
Economic burden of non-malignant blood disorders across Europe: a population-based cost study
|
Luengo-Fernandez, Ramon
|
|
2016
|
3 |
8 |
p. e371-e378
nvt p.
|
artikel
|
| 7 |
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
|
Raskob, Gary E
|
|
2016
|
3 |
8 |
p. e379-e387
nvt p.
|
artikel
|
| 8 |
Health-care use drives the economic burden of blood disorders in Europe
|
Pauwels, Kim
|
|
2016
|
3 |
8 |
p. e355-e356
nvt p.
|
artikel
|
| 9 |
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
|
Illerhaus, Gerald
|
|
2016
|
3 |
8 |
p. e388-e397
nvt p.
|
artikel
|
| 10 |
High-dose therapy for primary CNS lymphoma
|
Hohaus, Stefan
|
|
2016
|
3 |
8 |
p. e359-e360
nvt p.
|
artikel
|
Tijdschrift beschrijving